Brasada Capital Management, LP Vertex Pharmaceuticals Inc Transaction History

Brasada Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$207.01 - $276.09 $2.4 Million - $3.2 Million	-11,591 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$255.65 - $303.1 $261,785 - $310,374	-1,024 Reduced 8.12%	11,591 $3.15 Million
Q2 2020 Jul 14, 2020	BUY	$225.48 - $295.8 $238,332 - $312,660	1,057 Added 9.15%	12,615 $3.66 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $293,262 - $363,785	1,468 Added 14.55%	11,558 $2.75 Million
Q4 2019 Jan 14, 2020	BUY	$166.71 - $223.91 $1.68 Million - $2.26 Million	10,090 New	10,090 $2.21 Million

1,708

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Brasada Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Brasada Capital Management, LP with notifications on news.